Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019;21(4):154-157.

Long-term Consequences of Medical Therapy for Benign Prostatic Hyperplasia

Eric M Bortnick  1 , Vannita Simma-Chiang  1 , Steven A Kaplan  1
Affiliations

Long-term Consequences of Medical Therapy for Benign Prostatic Hyperplasia

Eric M Bortnick et al. Rev Urol. 2019.

Abstract

Benign prostatic hyperplasia (BPH) is a common disease in men. Although transurethral resection of the prostate (TURP) is the gold standard therapy for treatment of BPH and associated lower urinary tract symptoms (LUTS), many patients choose to avoid surgery and instead choose medical therapy. Until recently, medical therapy for BPH has been thought to be both safe and effective. However, new studies have shown that some of these medications can have significant neurocognitive, psychiatric, and sexual side effects, including dementia and depression. As most patients taking these medications will continue them for the long term, it is vital for physicians to explain these potential risks to the patient prior to prescribing them for a quality-of-life condition.

Keywords: 5-alpha-Reductase inhibitors; Benign prostatic hyperplasia; Dementia; Depression; Medical therapy; alpha-Blockers.

PubMed Disclaimer

References

    1. McVary KT Epidemiology and pathogenesis of benign prostatic hyperplasia. UpToDate website. https://www.uptodate.com/contents/epidemiology-and-pathogenesis-of-benig.... Last updated May 16, 2019. Accessed November 25, 2019.
    1. Duan Y, Grady JJ, Albertsen PC, Helen Wu Z. Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia. Pharmacoepidemiol Drug Saf. 2018;27:340–348. - PubMed
    1. American Geriatrics Society 2015 Beers Criteria Update Expert Panel American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015;63:2227–2246. - PubMed
    1. Moga DC, Abner EL, Wu Q, Jicha GA. Bladder antimuscarinics and cognitive decline in elderly patients. Alzheimers Dement. 2017;3:139–148. - PMC - PubMed
    1. Kay G, Crook T, Rekeda L, et al. Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects. Eur Urol. 2006;50:317–326. - PubMed

LinkOut - more resources